10.32
4.44%
-0.48
After Hours:
10.30
-0.02
-0.19%
Benitec Biopharma Inc (BNTC) Stock Split History
Benitec Biopharma Inc has split its stock 5 times since its initial public offering (IPO). The first stock split occurred on May 30, 2014 with the ratio of 200-for-1, meaning that for 1 share of BNTC owned pre-split, shareholders then owned 200 shares. 4 more splits have been implemented since then. The most recent stock split took place on July 26, 2023 on a 1-for-17 basis.
These splits have increased BNTC stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that these actions only change the number of shares and the price per share with no impact on Benitec Biopharma Inc's total market capitalization.
For more detailed information of Benitec Biopharma Inc's stock splits, view the table below:
These splits have increased BNTC stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that these actions only change the number of shares and the price per share with no impact on Benitec Biopharma Inc's total market capitalization.
For more detailed information of Benitec Biopharma Inc's stock splits, view the table below:
BNTC stock split list
Date | Split Ratio |
---|---|
2023-07-26 | 1 - for - 17 |
2020-04-15 | 2 - for - 3 |
2019-11-18 | 1 - for - 10 |
2015-06-16 | 1 - for - 4 |
2014-05-30 | 200 - for - 1 |
Will Benitec Biopharma Inc Stock Split in 2024?
The answer will depend on the decisions of the company's managers and market volatility. Benitec Biopharma Inc has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when BNTC stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Benitec Biopharma Inc's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.
Stock Splits of Industry Leaders
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):